Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_03880 |
| Species: | Mus musculus |
| Position : | chr4:101250000-101250600 |
| Year: | 2014 |
| Title: | Reorganization of enhancer patterns in transition from naive to primed pluripotency. |
| Genome Build: | mm10 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| PMID: | 24905168 |
| Tissue: | embryo |
| Tissue Ontology ID: | UBERON:0000922 |
| Cell Source: | Epiblast-like cells (EpiLC) |
| Cell Type: | epiblast-like cell |
| Experiment Type: | Enhancer activity assay |
| High Throughput Method: | ChIP-seq; RNA-seq |
| Low Throughput Method: | Transgenic reporter assay |
| Target gene : | Pou3f1 |
| TF name : | Pou5f1 |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|---|---|---|
| Pou5f1 | HIF-2-alpha transcription factor network | pid | 34 |
| Pou5f1 | POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | reactome | 13 |
| Pou5f1 | POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | reactome | 10 |
| Pou5f1 | Transcriptional regulation of pluripotent stem cells | reactome | 28 |
| Pou5f1 | Hs_Endoderm_Differentiation_WP2853_88152 | wikipathways | 62 |
| Pou5f1 | Hs_Wnt_Signaling_Pathway_and_Pluripotency_WP399_90291 | wikipathways | 12 |
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_03879 | chr4:101250000-101250600 | embryo | epiblast-like cell | NA |